Target intelligence / Profile preview

PRR29 antisense RNA 1 (PRR29-AS1)

Target
PRR29-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA
01

Overview

PRR29 antisense RNA 1 (PRR29-AS1) is a long noncoding RNA (lncRNA) gene located on human chromosome 17. It is transcribed from the opposite strand of the PRR29 protein-coding gene. PRR29-AS1 is categorized as an antisense RNA, a class of lncRNAs that may regulate the expression of neighboring or overlapping coding genes, although no direct functional roles, biological pathways, or disease associations have yet been described for this specific RNA[2][3][8][10]. There are no current reports of PRR29-AS1 being a therapeutic target, nor are there data on interacting drugs, mechanisms of action, biomarker utility, or safety considerations in a clinical context.

Other names
PRR29-AS1RP11-445K13.2ENSG00000264954ENST00000501158ENST00000580942.1
02

Biological functions

Unknown (generally, antisense lncRNAs can regulate gene expression at transcriptional or post-transcriptional levels, but no direct data for PRR29-AS1)
03

Disease associations

None known (no established association with disease)

Beyond the preview

Go deeper on PRR29 antisense RNA 1 (PRR29-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRR29 antisense RNA 1 (PRR29-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call